chronic myelocytic leukemia

(redirected from Chronic myelogenous leukemia)
Also found in: Thesaurus, Medical, Financial, Acronyms, Encyclopedia, Wikipedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.chronic myelocytic leukemia - chronic leukemia characterized by granular leukocytes; more common in older people
chronic leukemia - slowly progressing leukemia
granulocytic leukemia, myelocytic leukemia - a malignant neoplasm of blood-forming tissues; marked by proliferation of myelocytes and their presence in the blood
References in periodicals archive ?
The Type II Variation application for Bosulif for adults with newly diagnosed chronic phase Ph+ CML was based on results from BFORE (Bosutinib trial in First line chrOnic myelogenous leukemia tREatment), a randomized multicenter, multinational, open-label, Phase 3, head-to-head study of Bosulif 400 mg versus imatinib 400 mg, a current standard of care.
Over the last 10 years biopharmaceutical researchers have leveraged cutting-edge technologies and dramatically expanded our understanding of rare diseases to develop new therapies for chronic myelogenous leukemia, cystic fibrosis and other diseases which often impact very small patient populations.
Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia.
An adolescent girl with chronic myelogenous leukemia was treated with hypnosis for several disease- and treatment-related problems during the last 4 months of her life.
The team, led by Dr Veronika Sexl from the University of Vienna, carried out their research on acute lymphoid leukemia (ALL) and chronic myelogenous leukemia (CML), which can both be caused by fusion protein, Bcr-Abl, created through the joining of two or more genes originally coded for separate proteins.
It is also investigated for additional indications, such as Myelodysplastic Syndrome (MDS) and Chronic Myelogenous Leukemia (CML).
There are four major types of leukemia: acute myelogenous leukemia (AML), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), and chronic lymphocytic leukemia (CLL).
Imatinib mesylate, an inhibitor of Bcr-Abl tyrosine kinases, has revolutionized the treatment of chronic myelogenous leukemia (CML), showing marked improvements in survival in all three phases of the disease: chronic, accelerated, and blast crisis (see Figure 1).
Then the Inquirer's assistant sports editor, he detailed his condition one year after being diagnosed with chronic myelogenous leukemia.
ORLANDO -- Dasatinib, an oral, small-molecule inhibitor of tyrosine kinase, continues to yield favorable response rates in patients with chronic myelogenous leukemia who are resistant or intolerant to imatinib, investigators reported at the annual meeting of the American Society of Hematology.

Full browser ?